Document Classification

Section Type: METHODS

Text: Subjects with hypercholesterolemia (plasma low density lipoprotein [LDL] cholesterol level > 160 mg/dL and triglyceride level < or = 300 mg/dL) were randomly assigned to receive daily doses of placebo (n = 33), colesevelam 3. 8 g (recommended dose, n = 37), simvastatin 10 mg (n = 35), colesevelam 3. 8 g with simvastatin 10 mg (n = 34), colesevelam 2. 3 g (low dose, n = 36), simvastatin 20 mg (n = 39), or colesevelam 2. 3 g with simvastatin 20 mg (n = 37), for 6 weeks.